Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-κB–driven inflammation and cardiovascular risk
Anthony S Zannas,Meiwen Jia,Kathrin Hafner,Jens Baumert,Tobias Wiechmann,Julius C Pape,Janine Arloth,Maik Ködel,Silvia Martinelli,Maria Roitman,Simone Röh,Andreas Haehle,Rebecca T Emeny,Stella Iurato,Tania Carrillo-Roa,Jari Lahti,Katri Räikkönen,Johan G Eriksson,Amanda J Drake,Melanie Waldenberger,Simone Wahl,Sonja Kunze,Susanne Lucae,Bekh Bradley,Christian Gieger,Felix Hausch,Alicia K Smith,Kerry J Ressler,Bertram Müller-Myhsok,Karl-Heinz Ladwig,Theo Rein,Nils C Gassen,Elisabeth B Binder,Anthony S. Zannas,Julius C. Pape,Rebecca T. Emeny,Johan G. Eriksson,Amanda J. Drake,Alicia K. Smith,Kerry J. Ressler,Nils C. Gassen,Elisabeth B. Binder
DOI: https://doi.org/10.1073/pnas.1816847116
IF: 11.1
2019-05-21
Proceedings of the National Academy of Sciences
Abstract:Significance Diseases of the aging are the leading cause of morbidity and mortality. Elucidating the molecular mechanisms through which modifiable factors, such as psychosocial stress, confer risk for aging-related disease can have profound implications. By combining studies in humans with experiments in cells, we show that aging and stress synergize to epigenetically upregulate FKBP5, a protein implicated in stress physiology. Higher FKBP5 promotes inflammation by activating the master immune regulator NF-κB, whereas opposing FKBP5, either genetically or pharmacologically, prevents the effects on NF-κB. Further, the aging/stress-related epigenetic signature of FKBP5 is associated with history of myocardial infarction, a disease linked to inflammation. These findings provide molecular insights into stress-related disease, pointing to biomarker and treatment possibilities.
multidisciplinary sciences